Literature DB >> 1592698

Resistance to a new catecholic cephem, BO-1341, in Pseudomonas aeruginosa PAO.

N Hazumi1, K Matsuda, M Sanada, N Ohtake, N Tanaka.   

Abstract

Two distinct types of mutant resistant to the catecholic cephem BO-1341 were isolated spontaneously from Pseudomonas aeruginosa PAO2146: (i) a mutant (CCB5-type) which produced beta-lactamase constitutively, and which appeared to result from a mutation in the regulatory gene (blaI at 41 min) controlling the structural gene (blaP at 25 min); (ii) a mutant (CCB7-type) with specific resistance to BO-1341. Induction of beta-lactamase production in strain CCB7 by BO-1341 was diminished markedly when compared with that in the parent strain. This was not the case for ceftazidime or cefoxitin, suggesting impaired uptake of BO-1341 as an explanation for the resistance. Electrophoretic analysis demonstrated increased production of a 55 kDa protein in the periplasmic space and a 84 kDa outer membrane protein. These data suggested that specific resistance to BO-1341 might involve quantitative alterations in the composition of the outer membrane and periplasmic proteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1592698     DOI: 10.1093/jac/29.3.287

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  2 in total

1.  Antibacterial activity of BMS-180680, a new catechol-containing monobactam.

Authors:  J Fung-Tomc; K Bush; B Minassian; B Kolek; R Flamm; E Gradelski; D Bonner
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

2.  Mechanism of enhanced antipseudomonal activity of BO-2727, a new injectable 1-beta-methyl carbapenem.

Authors:  N Hazumi; A Fuse; K Matsuda; T Hashizume; M Sanada
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.